An Observational Study of Continued Avastin Plus Chemotherapy Until First Progression in Patients With Metastatic Colorectal Cancer
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 18 Sep 2017
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Roche
- 11 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 01 Sep 2016 Planned End Date changed from 1 Mar 2018 to 1 Dec 2017.
- 01 Sep 2016 Planned primary completion date changed from 1 Mar 2018 to 1 Dec 2017.